Chronic Disease Management Market, By Platform Type, By Service Type, By Disease Type, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

Description

REPORT HIGHLIGHT

Chronic Disease Management Market size was valued at USD 5,109.32 Million in 2023, expanding at a CAGR of 14.90% from 2024 to 2032.

The Chronic Disease Management Market encompasses various strategies and technologies designed to improve health outcomes for individuals with chronic conditions. Chronic disease management involves the ongoing care and support of patients with long-term illnesses like diabetes, hypertension, and heart disease, with approximately 60% of adults in the U.S. living with at least one chronic condition. Rising healthcare costs, an aging population, and increasing awareness about preventive healthcare are significant factors propelling the demand for chronic disease management solutions. However, challenges such as high implementation costs, lack of skilled professionals, and patient non-compliance can hinder market growth. On the flip side, opportunities abound in the form of advancements in telemedicine, the growing integration of artificial intelligence in healthcare, and the increasing focus on personalized medicine, which can enhance the effectiveness of chronic disease management programs and improve patient adherence.

Chronic Disease Management Market- Market Dynamics

Growing Emphasis on Preventive Healthcare Fuels Expansion of the Chronic Disease Management Market

The growing emphasis on preventive healthcare is significantly driving the expansion of the Chronic Disease Management Market, as organizations and governments increasingly recognize the importance of early intervention and ongoing care. According to the Centers for Disease Control and Prevention (CDC), chronic diseases account for 7 of the 10 leading causes of death in the United States, highlighting the urgent need for effective management strategies. A study by the National Institute of Health found that lifestyle changes and preventive measures could reduce the risk of developing chronic diseases by 80%. Furthermore, initiatives like the World Health Organization's Global Action Plan aim to reduce premature mortality from non-communicable diseases by 25% by 2025, reinforcing the necessity for comprehensive chronic disease management programs that focus on prevention.

Chronic Disease Management Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.90% over the forecast period (2024-2032)

Based on Platform Type segmentation, Cloud-based solutions was predicted to show maximum market share in the year 2023

Based on Service Type segmentation, Care coordination was the leading type in 2023

Based on Disease Type segmentation, cardiovascular diseases was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Chronic Disease Management Market- Segmentation Analysis:

The Global Chronic Disease Management Market is segmented on the basis of Platform Type, Service Type, Disease Type, End-User, and Region.

The market is divided into three categories based on Platform Type: Web-Based Solutions, Cloud-Based Solutions, and On-Premise Solutions. Cloud-based solutions lead in popularity due to their scalability and accessibility, followed by web-based solutions that offer user-friendly interfaces for patients and providers. On-premise solutions rank third, primarily used by large healthcare organizations for data security.

The market is divided into Four categories based on Service Type: Consulting, Care Coordination, Education & Training, and Monitoring & Assessment. Care coordination services are prioritized for their critical role in patient management, followed by monitoring and assessment services that ensure ongoing evaluation. Consulting ranks third, while education and training services are essential for empowering patients.

Chronic Disease Management Market- Geographical Insights

The Chronic Disease Management Market exhibits diverse geographical dynamics, with North America leading the charge, driven by high healthcare expenditure and advanced infrastructure. In the U.S., initiatives like the CDC's National Diabetes Prevention Program have successfully reduced diabetes incidence among participants by 58%. Europe follows closely, where countries like Germany and the UK are prioritizing integrated care models to manage chronic diseases effectively, as evidenced by the NHS's commitment to diabetes management programs, which aim to improve outcomes for over 1 million patients. The Asia-Pacific region is rapidly emerging, fueled by rising awareness and a growing elderly population; for instance, Japan's health ministry has implemented a unique health management initiative targeting obesity and metabolic syndrome to combat chronic diseases. In Latin America, Brazil is working towards a more preventive healthcare model, focusing on public health campaigns to address hypertension and diabetes. Lastly, the Middle East and Africa are seeing increasing investment in healthcare technology, with initiatives aimed at enhancing chronic disease management through telehealth services and community health programs.

Chronic Disease Management Market- Competitive Landscape:

The competitive landscape of the Chronic Disease Management Market is shaped by key players across various regions, each actively working to enhance patient care. North America remains a leader, with companies like UnitedHealth Group and Cigna investing in innovative digital health platforms to streamline chronic disease management; initiatives such as the CMS Chronic Care Management program have successfully enrolled over 300,000 Medicare beneficiaries to improve care coordination. In Europe, major players like Bayer and Sanofi focus on comprehensive care models, supported by EU health initiatives aimed at reducing chronic disease prevalence by 20% by 2025. The Asia-Pacific region is witnessing rapid growth, with organizations like Philips launching telehealth services that increased by 140% in usage during the pandemic in countries like Australia. Latin America is also emerging, with initiatives such as Brazil's "Saude na Hora," which aims to provide accessible chronic disease management services across underserved communities. Meanwhile, the Middle East and Africa see increasing investments in healthcare technology, driven by firms like Siemens Healthineers, enhancing access to care and improving management strategies in the region.

Recent Developments:

In January 2024, Amazon launched a chronic condition management program in partnership with Omada Health, connecting users to services for diabetes and weight management. The initiative aims to help consumers access eligible benefits through Amazon's platform, enhancing healthcare accessibility

In February 2022, Teladoc Health launched its Chronic Care Complete program, targeting diabetes, prediabetes, and hypertension management. The initiative includes connected devices, personal health coaches, and mental health support, available through health plans or employers to enhance patient care and management.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CHRONIC DISEASE MANAGEMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Allscripts Healthcare Solutions, Inc.
Altruista Health, Inc.
Cerner Corporation
Cognizant Technology Solutions Corporation
Epic Systems Corporation
GE Healthcare
Health Catalyst, Inc.
i2i Population Health
IBM Corporation
Infosys Limited
Koninklijke Philips N.V.
McKesson Corporation
Medtronic plc
Pegasystems Inc.
Siemens Healthineers AG
ZeOmega, Inc.
Others

GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY PLATFORM TYPE- MARKET ANALYSIS, 2019 - 2032

Web-Based Solutions
Cloud-Based Solutions
On-Premise Solutions

GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY SERVICE TYPE- MARKET ANALYSIS, 2019 - 2032

Consulting
Care Coordination
Education & Training
Monitoring & Assessment

GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019 - 2032

Diabetes
Cardiovascular Diseases
Respiratory Diseases
Cancer
Others

GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

Hospitals & Clinics
Homecare
Diagnostic Centers
Payers

GLOBAL CHRONIC DISEASE MANAGEMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV3993

1. Chronic Disease Management Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Chronic Disease Management Market Snippet by Platform Type
- 2.1.2. Chronic Disease Management Market Snippet by Service Type
- 2.1.3. Chronic Disease Management Market Snippet by Disease Type
- 2.1.4. Chronic Disease Management Market Snippet by End-User
- 2.1.5. Chronic Disease Management Market Snippet by Country
- 2.1.6. Chronic Disease Management Market Snippet by Region
2.2. Competitive Insights

3. Chronic Disease Management Key Market Trends

3.1. Chronic Disease Management Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Chronic Disease Management Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Chronic Disease Management Market Opportunities
3.4. Chronic Disease Management Market Future Trends

4. Chronic Disease Management Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Chronic Disease Management Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Chronic Disease Management Market Landscape

6.1. Chronic Disease Management Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Chronic Disease Management Market - By Platform Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Platform Type, 2023 & 2032 (%)
- 7.1.2. Web-Based Solutions
- 7.1.3. Cloud-Based Solutions
- 7.1.4. On-Premise Solutions

8. Chronic Disease Management Market - By Service Type

8.1. Overview
- 8.1.1. Segment Share Analysis, By Service Type, 2023 & 2032 (%)
- 8.1.2. Consulting
- 8.1.3. Care Coordination
- 8.1.4. Education & Training
- 8.1.5. Monitoring & Assessment

9. Chronic Disease Management Market - By Disease Type

9.1. Overview
- 9.1.1. Segment Share Analysis, By Disease Type, 2023 & 2032 (%)
- 9.1.2. Diabetes
- 9.1.3. Cardiovascular Diseases
- 9.1.4. Respiratory Diseases
- 9.1.5. Cancer
- 9.1.6. Others

10. Chronic Disease Management Market - By End-User

10.1. Overview
- 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
- 10.1.2. Hospitals & Clinics
- 10.1.3. Homecare
- 10.1.4. Diagnostic Centers
- 10.1.5. Payers

11. Chronic Disease Management Market- By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. Chronic Disease Management Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. Chronic Disease Management Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.9. Italy
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3. Italy Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
  - 11.3.9.4. Italy Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.9.5. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.10. United Kingdom
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3. United Kingdom Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
  - 11.3.10.4. United Kingdom Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.10.5. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.11. France
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3. France Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
  - 11.3.11.4. France Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.11.5. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.12. Russia
  - 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.2. Russia Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
  - 11.3.12.3. Russia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.12.4. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.13. Netherlands
  - 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.2. Netherlands Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
  - 11.3.13.3. Netherlands Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.13.4. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.2. Sweden Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.15. Poland
  - 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.2. Poland Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
  - 11.3.15.3. Poland Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.15.4. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.16. Rest of Europe
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3. Rest of the Europe Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
  - 11.3.16.4. Rest of the Europe Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.3.16.5. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Chronic Disease Management Key Manufacturers in Asia Pacific
- 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. Asia Pacific Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
- 11.4.5. Asia Pacific Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
- 11.4.6. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.8. India
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3. India Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
  - 11.4.8.4. India Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.8.5. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.9. China
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3. China Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
  - 11.4.9.4. China Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.9.5. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.13. Thailand
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3. Thailand Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
  - 11.4.13.4. Thailand Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.13.5. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.14. Indonesia
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3. Indonesia Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
  - 11.4.14.4. Indonesia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.14.5. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3. Rest of APAC Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
  - 11.4.16.4. Rest of APAC Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.4.16.5. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5. Latin America
- 11.5.1. Overview
- 11.5.2. Chronic Disease Management Key Manufacturers in Latin America
- 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. Latin America Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
- 11.5.5. Latin America Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
- 11.5.6. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa
- 11.6.1. Overview
- 11.6.2. Chronic Disease Management Key Manufacturers in Middle East and Africa
- 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. Middle East and Africa Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
- 11.6.5. Middle East and Africa Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
- 11.6.6. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3. Rest of MEA Market Size and Forecast, By Platform Type, 2019 - 2032 (US$ Million)
  - 11.6.14.4. Rest of MEA Market Size and Forecast, By Service Type, 2019 - 2032 (US$ Million)
  - 11.6.14.5. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
  - 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Chronic Disease Management Industry

12.1. Competitive Dashboard
12.2. Company Profiles
- 12.2.1. Allscripts Healthcare Solutions, Inc.
- 12.2.2. Altruista Health, Inc.
- 12.2.3. Cerner Corporation
- 12.2.4. Cognizant Technology Solutions Corporation
- 12.2.5. Epic Systems Corporation
- 12.2.6. GE Healthcare
- 12.2.7. Health Catalyst, Inc.
- 12.2.8. i2i Population Health
- 12.2.9. IBM Corporation
- 12.2.10. Infosys Limited
- 12.2.11. Koninklijke Philips N.V.
- 12.2.12. McKesson Corporation
- 12.2.13. Medtronic plc
- 12.2.14. Pegasystems Inc.
- 12.2.15. Siemens Healthineers AG
- 12.2.16. ZeOmega, Inc.
- 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us